• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
LI Changxing,YU Yao,ZHANG Lixue,MA Lina,YANG Aiping.Exploration on the mechanism of Tibetan Medicine Ershiwu Wei Guijiu Pill in preventing postmenopausal osteoporosis based on transcriptomics[J].Journal Of Pharmaceutical Research,2025,44(12):1173-1179[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2288times   Download 778次 QR Code for this article
Scan with your phone!
基于转录组学探讨藏药二十五味鬼臼丸防治绝经后骨质疏松症的作用机制
李长兴1,余瑶2,张立雪3,马莉娜1,杨爱萍4
Font:Larger+|Default|Smaller-
(1.青海大学医学院基础医学部,青海 西宁 810016;2.新疆和田学院,新疆 和田 848000;3.西北民族大学医学部,甘肃 兰州 730030;4.青海红十字医院,青海 西宁 810000)
摘要:
目的 基于转录组学技术探讨藏药二十五味鬼臼丸(GJW)对绝经后骨质疏松症(PMOP)大鼠的基因表达及分子机制。方法 将36只3月龄SD雌性大鼠随机分为假手术组(Sham)、模型组(OVX)和GJW组,药物干预12周后取大鼠股骨,采用RNA-Seq技术进行转录组测序,并对测序结果进行GO注释和KEGG富集分析;通过RT-qPCR和Western blot验证测序结果。结果 转录组测序共筛选出190个差异基因,其中GJW组上调153个,下调690个。GO 分析表明,差异基因主要参与肌原纤维形成、B 细胞受体信号通路、线粒体翻译等生物过程,定位于免疫球蛋白复合体、线粒体蛋白复合体等细胞组分,行使免疫球蛋白受体结合等分子功能。KEGG分析发现钙信号通路、焦点粘附、ECM-受体相互作用、MAPK等通路显著富集。RT-qPCR验证结果表明,3个差异基因在GJW组显著下调,与WB结果一致。结论 转录组分析揭示藏药二十五味鬼臼丸通过调节与肌肉收缩和钙运输相关的基因及信号通路,可能改善PMOP大鼠的骨骼结构与新陈代谢,这为PMOP的临床诊断提供潜在生物标志物。
关键词:  绝经后骨质疏松症  藏药二十五味鬼臼丸  钙信号通路  转录组学
DOI:10.13506/j.cnki.jpr.2025.12.005
基金项目:青海省科技计划项目(No.2023-ZJ-783);青海大学青年科研基金项目(No.2023-QYY-1);青海大学医学部中青年科研基金项目(No.2023-kyy-7)
Publication Date:December 25, 2025
Exploration on the mechanism of Tibetan Medicine Ershiwu Wei Guijiu Pill in preventing postmenopausal osteoporosis based on transcriptomics
LI Changxing1,YU Yao2,ZHANG Lixue3,MA Lina1,YANG Aiping4
(1. Department of Basic Medical Science, Qinghai University Medical College,Xining 810016, China; 2. Xinjiang Hetian College, Hetian 848000, China; 3. Medical Institute of Northwest Minzu University, Lanzhou 730030,China; 4. Qinghai Red Cross Hospital, Xining 810099, China)
Abstract:
Objective Based on transcriptomics technology, this study explores the gene expression and molecular mechanism of the Tibetan medicine Ershiwu Wei Guijiu Pill (GJW) in rats with postmenopausal osteoporosis (PMOP). Methods Thirty-six 3-month-old Sprague-Dawley (SD) female rats were randomly assigned to Sham, OVX (model), and GJW treatment groups. After 12 weeks of intervention, the femurs were harvested for RNA sequencing (RNA-Seq). The sequencing data were analyzed using Gene Ontology (GO) annotation and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis. Real-time quantitative PCR (RT-qPCR) and Western blotting were employed to validate the transcriptomic results.Results A total of 190 differentially expressed genes (DEGs) were identified, with 153 genes upregulated and 690 genes downregulated in the GJW group. GO analysis demonstrated that the differentially expressed genes were mainly involved in biological processes such as myofibril formation, B-cell receptor signaling pathway, and mitochondrial translation, were localized in cellular components like immunoglobulin complexes and mitochondrial protein complexes, and exerted molecular functions like immunoglobulin receptor binding. KEGG pathway analysis identified significant enrichment in pathways related to calcium signaling, focal adhesion, ECM-receptor interactions, and MAPK signaling. RT-qPCR results confirmed the downregulation of three specific DEGs in the GJW group, and Western blot results corroborated these findings. Conclusion Transcriptomic analysis indicated that the Ershiwu Wei Guijiu Pill regulates genes and signaling pathways associated with muscle contraction and calcium transport, potentially improving skeletal structure and metabolism in PMOP rats. These findings suggest potential biomarkers for the clinical diagnosis of PMOP.
Key words:  Postmenopausal osteoporosis  Tibetan Medicine Ershiwu Wei Guijiu Pill  Calcium signaling pathway  Transcriptomics
Today's Visits:483    Total Visits:2383194
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.